TY - JOUR
AU - Fischer, Tom
AU - Maass, Kendra
AU - Puranachot, Pitithat
AU - Mieskolainen, Markus
AU - Sill, Martin
AU - Schad, Paulina
AU - Volz, Stefanie
AU - Rosing, Fabian
AU - Wedig, Tatjana
AU - Schwarz, Nathalie
AU - Finster, Agnes
AU - Iser, Florian
AU - Meyer, Jochen
AU - Sahm, Felix
AU - Lohi, Olli
AU - Damaty, Ahmed El
AU - Brors, Benedikt
AU - Haapasalo, Hannu
AU - Pfister, Stefan
AU - Haapasalo, Joonas
AU - Pajtler, Kristian
AU - Nordfors, Kristiina
TI - Ultra-low-input cell-free DNA sequencing for tumor detection and characterization in a real-world pediatric brain tumor cohort.
JO - Acta Neuropathologica Communications
VL - 13
IS - 1
SN - 2051-5960
CY - London
PB - Biomed Central
M1 - DKFZ-2025-01317
SP - 134
PY - 2025
N1 - #EA:B062#LA:B062#
AB - Molecular profiling of pediatric central nervous system (CNS) tumors has important clinical utility for guiding diagnostic and therapeutic strategies. Cell-free DNA (cfDNA) from liquid biopsies has been used for minimally invasive tumor profiling and longitudinal disease assessment in adult oncology and pediatric hematology. However, in pediatric neuro-oncology, low cfDNA yields pose a major barrier to translating these assays from bench to bedside. Here, we implemented a low-coverage whole genome sequencing (lcWGS) assay for picogram-level cfDNA inputs and applied it to liquid biopsies from a sizeable, population-based, cross-entity pediatric CNS tumor cohort (n = 56 patients). Applying this protocol, cfDNA whole genome profiles were successfully acquired from all liquid biopsy samples (n = 61/61 serum, n = 56/56 CSF, 100
KW - Humans
KW - Child
KW - Male
KW - Brain Neoplasms: genetics
KW - Brain Neoplasms: diagnosis
KW - Brain Neoplasms: cerebrospinal fluid
KW - Brain Neoplasms: blood
KW - Female
KW - Child, Preschool
KW - Adolescent
KW - Cohort Studies
KW - Whole Genome Sequencing: methods
KW - Biomarkers, Tumor: cerebrospinal fluid
KW - Biomarkers, Tumor: genetics
KW - Biomarkers, Tumor: blood
KW - Liquid Biopsy
KW - Circulating Tumor DNA: cerebrospinal fluid
KW - Circulating Tumor DNA: genetics
KW - Circulating Tumor DNA: blood
KW - Cell-Free Nucleic Acids
KW - Infant
KW - DNA Copy Number Variations
KW - Cell-free DNA (Other)
KW - Cerebrospinal fluid liquid biopsies (Other)
KW - Circulating-tumor DNA (Other)
KW - Copy number variation profiling (Other)
KW - Longitudinal molecular biomarkers (Other)
KW - Low-coverage whole genome sequencing (Other)
KW - Low-input samples (Other)
KW - Minimally-invasive disease monitoring (Other)
KW - Pediatric neuro-oncology (Other)
KW - Tumor evolution (Other)
KW - Biomarkers, Tumor (NLM Chemicals)
KW - Circulating Tumor DNA (NLM Chemicals)
KW - Cell-Free Nucleic Acids (NLM Chemicals)
LB - PUB:(DE-HGF)16
C6 - pmid:40579709
DO - DOI:10.1186/s40478-025-02024-w
UR - https://inrepo02.dkfz.de/record/302322
ER -